Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe save search
iSpecimen Expands Biospecimen Provider NetworkiSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and Europe
Published: 2023-02-08 (Crawled : 14:00) - biospace.com/
ISPC | $0.2845 -32.42% 1.7M
|
Professional, Scientific, and T...
|
| O: 3.18%
H: 0.55%
C: -2.48%
europe platform
Veru Announces the Presentation of a Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 European Association of Urology Annual Congress
Published: 2021-06-28 (Crawled : 13:00) - globenewswire.com
VERU | $1.365 -3.87% 1.7M
|
Health Technology
|
| O: 0.73%
H: 7.15%
C: 5.45%
presentation europe prostate cancer phase 1 cancer phase 1b sabizabulin phase 2b
Tiziana Life Sciences plc files scheme of arrangement to effect a corporate reorganisation
Published: 2021-08-20 (Crawled : 12:00) - biospace.com/
TLSA | News | $0.66 3.13% 420K
|
Health Technology
|
| O: -3.11%
H: 0.0%
C: -1.92%
life science
Europe Bitumen Additives Market Forecast to 2030: A US$ 2.16 Billion Market by 2030. with Estimated CAGR of 5.9% from 2022 to 2030
Published: 2024-03-09 (Crawled : 04:20) - prnewswire.com
SASOF | $8.735 340
|
Process Industries
| Email alert
Add to watchlist
europe market
VirTra Receives $1.3 Million Order from a Country in Europe
Published: 2021-10-05 (Crawled : 12:15) - globenewswire.com
VTSI | News | $13.055 -1.47% 71K
|
Producer Manufacturing
|
| O: 1.5%
H: 6.89%
C: 3.84%
europe order
Humacyte Announces Publication in Lancet Regional Health - Europe Presenting Use of Human Acellular Vessel™ (HAV™) to Treat Vascular Injuries in Ukraine
Published: 2023-05-09 (Crawled : 12:00) - globenewswire.com
HUMA | $3.72 3.62% 3.7M
|
Manufacturing
|
| O: 2.01%
H: 0.99%
C: -12.43%
europe lancet health publication
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2021-10-18 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $91.34 1.2% 2.9M
|
Finance
|
| O: -0.68%
H: 2.14%
C: -0.34%
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -0.59%
H: 1.77%
C: -3.44%
offering
Bicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences
Published: 2021-05-27 (Crawled : 12:15) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -0.9%
conference therapeutics
Bicycle Therapeutics to Present Five Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist® (Bicycle TICA®) Programs at the SITC 37th Annual Meeting
Published: 2022-11-10 (Crawled : 15:20) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 7.62%
H: 3.32%
C: 2.25%
agonist preclinical meeting therapeutics bicycle
Bicycle Therapeutics Announces Further Expansion of Genentech Immuno-Oncology Collaboration
Published: 2022-07-12 (Crawled : 12:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: -2.76%
expansion collaboration therapeutics bicycle
Bicycle Therapeutics Announces Publication of Article in Bioconjugate Chemistry, Describing an Extension of its Proprietary Technology Platform Based on Bicyclic Peptides
Published: 2022-08-02 (Crawled : 23:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 0.0%
H: 3.97%
C: 1.28%
extension technology therapeutics bicycle publication platform
Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates
Published: 2023-03-28 (Crawled : 12:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 5.85%
H: 5.81%
C: 4.92%
bicycle collaboration novartis therapeutics
Bicycle Therapeutics Announces Updated Preclinical Data on SARS-CoV-2 Antivirals at the 2022 Microbiology Society Annual Meeting
Published: 2022-04-07 (Crawled : 12:20) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 1.68%
H: 1.08%
C: -11.14%
preclinical therapeutics sars-cov-2 pre-clinical
Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-04 (Crawled : 12:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -1.97%
H: 1.68%
C: -2.34%
bicycle update therapeutics financial results
Bicycle Therapeutics to Present Trials in Progress Poster Featuring BT7480 Phase I/II Clinical Trial at the 2022 ASCO Annual Meeting
Published: 2022-05-26 (Crawled : 23:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -0.89%
H: 4.04%
C: -3.78%
bt7480 trials trial therapeutics asco
Bicycle Therapeutics to Present Four Posters Highlighting Preclinical Data from its Bicycle Tumor-Targeted Immune Cell Agonist™ (Bicycle TICA™) Programs at the SITC 36th Annual Meeting
Published: 2021-11-09 (Crawled : 16:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 1.64%
H: 1.04%
C: -2.78%
preclinical pre-clinical
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
Published: 2023-07-13 (Crawled : 08:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: 2.32%
H: 18.21%
C: 16.61%
bicycle offering therapeutics
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-09-05 (Crawled : 20:00) - biospace.com/
MS | News 0 d | $91.34 1.2% 2.9M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -0.72%
H: 2.67%
C: -0.27%
conference bicycle global therapeutics
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-20 (Crawled : 23:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -1.78%
H: 4.75%
C: 2.67%
business year bicycle therapeutics financial results
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BCYC | $24.515 0.1% 160K
|
Health Technology
|
| O: -2.71%
H: 0.65%
C: -1.25%
conference bicycle therapeutics
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
BSFC | $0.0822 27.64% 75M
|
Manufacturing
RWOD | $10.08 26.05% 5.6M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.